KEY FEATURES
| Full Name | Interferon Regulatory Factor 1 |
|---|---|
| Synonym | MAR |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.13ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human IRF1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human IRF1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human IRF1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human IRF1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human IRF1. You can calculate the concentration of Human IRF1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human IRF1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.94 | 1.91 | 6.9 | 0.86 | 2.03 | 6.81 |
| Standard deviation | 0.05 | 0.11 | 0.37 | 0.05 | 0.11 | 0.25 |
| CV(%) | 5.12 | 5.96 | 5.38 | 5.57 | 5.63 | 3.62 |
RECOVERY
The recovery of Human IRF1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-104 | 99 |
| EDTA plasma (n=8) | 90-103 | 95 |
| Cell culture media (n=8) | 90-102 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human IRF1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with IRF ELISA Kits
| STAT1 ELISA Kit | publications with IRF and STAT1 |
| IFNA2 ELISA Kit | publications with IRF and IFNA2 |
| STAT3 ELISA Kit | publications with IRF and STAT3 |
| CIITA ELISA Kit | publications with IRF and CIITA |
| IRF8 ELISA Kit | publications with IRF and IRF8 |
| IFNG ELISA Kit | publications with IRF and IFNG |
| STAT4 ELISA Kit | publications with IRF and STAT4 |
| GBP1 ELISA Kit | publications with IRF and GBP1 |
| HLA-B ELISA Kit | publications with IRF and HLA-B |
| EP300 ELISA Kit | publications with IRF and EP300 |
Pathways associated with IRF ELISA Kit
| Apoptosis Pathway | Apoptosis Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| Factors Involved In Megakaryocyte Development And Platelet Production Pathway | Factors Involved In Megakaryocyte Development And Platelet Production Pathway |
| Glucocorticoid Receptor Regulatory Network Pathway | Glucocorticoid Receptor Regulatory Network Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
| Hepatitis C Pathway | Hepatitis C Pathway |
| IFN-gamma Pathway | IFN-gamma Pathway |
| IL-7 Signaling Pathway | IL-7 Signaling Pathway |
| IL12 Signaling Mediated By STAT4 Pathway | IL12 Signaling Mediated By STAT4 Pathway |
Diseases associated with IRF ELISA Kit
| Necrosis | publications with IRF and Necrosis |
| Inflammation | publications with IRF and Inflammation |
| Liver Diseases | publications with IRF and Liver Diseases |
| Adenocarcinoma | publications with IRF and Adenocarcinoma |
| Hepatitis | publications with IRF and Hepatitis |
| Breast Neoplasms | publications with IRF and Breast Neoplasms |
| Lung Diseases | publications with IRF and Lung Diseases |
| Cell Transformation, Neoplastic | publications with IRF and Cell Transformation, Neoplastic |
| Neoplasms, Experimental | publications with IRF and Neoplasms, Experimental |
| Kidney Diseases | publications with IRF and Kidney Diseases |
Organs/Tissues associated with IRF ELISA Kit
| Blood | publications with IRF and Blood |
| Liver | publications with IRF and Liver |
| Vascular | publications with IRF and Vascular |
| Bone | publications with IRF and Bone |
| Lung | publications with IRF and Lung |
| Spleen | publications with IRF and Spleen |
| Bone Marrow | publications with IRF and Bone Marrow |
| Brain | publications with IRF and Brain |
| Muscle | publications with IRF and Muscle |
| Skin | publications with IRF and Skin |